ZA895142B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA895142B
ZA895142B ZA895142A ZA895142A ZA895142B ZA 895142 B ZA895142 B ZA 895142B ZA 895142 A ZA895142 A ZA 895142A ZA 895142 A ZA895142 A ZA 895142A ZA 895142 B ZA895142 B ZA 895142B
Authority
ZA
South Africa
Prior art keywords
medicaments
Prior art date
Application number
ZA895142A
Other languages
English (en)
Inventor
Keith Thomas Bunce
Thomas Bunce Keith
Patrick Paul Anthony Humphrey
Paul Anthony Humphrey Patrick
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA895142B publication Critical patent/ZA895142B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA895142A 1988-07-07 1989-07-06 Medicaments ZA895142B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816187A GB8816187D0 (en) 1988-07-07 1988-07-07 Medicaments

Publications (1)

Publication Number Publication Date
ZA895142B true ZA895142B (en) 1990-06-27

Family

ID=10640032

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895142A ZA895142B (en) 1988-07-07 1989-07-06 Medicaments

Country Status (14)

Country Link
US (1) US4983621A (hu)
JP (1) JPH0276815A (hu)
AU (1) AU633496B2 (hu)
BE (1) BE1002295A5 (hu)
CA (1) CA1330306C (hu)
CH (1) CH679553A5 (hu)
DE (1) DE3922263A1 (hu)
DK (1) DK336489A (hu)
FR (1) FR2633831B1 (hu)
GB (2) GB8816187D0 (hu)
IT (1) IT1232155B (hu)
NL (1) NL8901727A (hu)
SE (1) SE8902458L (hu)
ZA (1) ZA895142B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
DE01991193T1 (de) * 2000-10-30 2004-07-08 Teva Pharmaceutical Industries Ltd. Neue kristall- und solvatformen von ondansetronhydrochlorid und verfahren zu deren herstellung
PT1499623E (pt) * 2002-04-29 2007-08-10 Teva Gyogyszergyar Zartkoeruee ''processo papa a preparação de 1, 2, 3, 9-tetra-hidro-9-metil-3- [(2-metil-1h-imidazol-1-il) metil] -4h-carbazol-4-ona''
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
AU2003257060A1 (en) * 2002-07-31 2004-02-16 Sepracor Inc. Cyclooxygenase-2 inhibitors for appetite suppression
EP2124897A4 (en) * 2006-12-22 2012-05-09 Novadel Pharma Inc SPRAYING, ORAL, STABLE, SPRAY PREPARATIONS AND ASSOCIATED METHODS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB105193A (en) * 1916-08-29 1917-04-05 Thomas Joseph Mills Improvements in Rotary Printing Machines.
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
AU528310B2 (en) * 1978-11-16 1983-04-21 Beecham Group Plc Composition of paracetamol and metoclopramide
CY1398A (en) * 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
IT8948163A0 (it) 1989-07-06
NL8901727A (nl) 1990-02-01
FR2633831B1 (fr) 1993-11-19
AU3790489A (en) 1990-01-11
GB2220352B (en) 1992-03-18
CH679553A5 (hu) 1992-03-13
GB8816187D0 (en) 1988-08-10
GB2220352A (en) 1990-01-10
SE8902458L (sv) 1990-01-08
AU633496B2 (en) 1993-02-04
GB8915499D0 (en) 1989-08-23
IT1232155B (it) 1992-01-25
SE8902458D0 (sv) 1989-07-06
CA1330306C (en) 1994-06-21
FR2633831A1 (fr) 1990-01-12
DK336489D0 (da) 1989-07-06
JPH0276815A (ja) 1990-03-16
DK336489A (da) 1990-01-08
BE1002295A5 (fr) 1990-11-20
DE3922263A1 (de) 1990-01-11
US4983621A (en) 1991-01-08

Similar Documents

Publication Publication Date Title
GB8819477D0 (en) Medicaments
GB8905400D0 (en) Medicaments
GB8915499D0 (en) Medicaments
GB8904881D0 (en) Medicaments
GB8904879D0 (en) Medicaments
GB8814726D0 (en) Medicaments
ZA896675B (en) Medicaments
GB8808599D0 (en) Medicaments
GB8820650D0 (en) Medicaments
GB8814725D0 (en) Medicaments
GB8820653D0 (en) Medicaments
GB8911166D0 (en) Medicaments
GB8828032D0 (en) Medicaments
ZA896227B (en) Medicaments
GB8811167D0 (en) Medicaments
GB8814728D0 (en) Medicaments
GB8814053D0 (en) Medicaments
GB8814727D0 (en) Medicaments
GB8812173D0 (en) Medicaments
GB8811311D0 (en) Medicaments
GB8827007D0 (en) Medicaments
GB8826394D0 (en) Medicaments
GB8826288D0 (en) Medicaments
GB8826287D0 (en) Medicaments
GB8825392D0 (en) Medicaments